Search clinical trials for: RG7388
Total 37 results
-
Hoffmann-La RocheTerminatedPolycythemia VeraUnited States, Canada, Italy, Australia
-
Hoffmann-La RocheCompletedAutism Spectrum DisorderUnited States
-
Genentech, Inc.TerminatedCrohn's Disease | Ulcerative ColitisGermany, Italy, Poland, Russian Federation, Serbia, United States, Ukraine, Bulgaria, Georgia, Greece, Ireland, Moldova, Republic of, Spain, United Kingdom
-
Genentech, Inc.CompletedCrohn's Disease | Ulcerative ColitisUnited Kingdom, Germany
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
Kissei Pharmaceutical Co., Ltd.CompletedIdiopathic Thrombocytopenic PurpuraJapan
-
Rigel PharmaceuticalsCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Rigel PharmaceuticalsCompleted
-
Rigel PharmaceuticalsWithdrawnSystemic Lupus Erythematosus
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, United States, Australia, Poland, United Kingdom, Canada, Czechia, Bulgaria, Romania, Austria, Denmark, Hungary, Italy, Netherlands, Norway
-
John MascarenhasRoche Pharma AG; The Leukemia and Lymphoma SocietyCompletedPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraUnited States, Australia, United Kingdom, Canada, Italy, Denmark, Hungary, Netherlands
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, Norway, Poland, Czechia, Germany, United States, Austria, Bulgaria, Romania
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedUlcerative ColitisItaly, Spain, Serbia, Poland, Russian Federation, United States, Ukraine, Bulgaria, Georgia, Germany, Greece, Hungary, Ireland, Israel, Moldova, Republic of, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminatedAcute Myeloid LeukemiaSpain, United States, France, Australia, Italy
-
Rigel PharmaceuticalsNo longer availableImmune Thrombocytopenic Purpura
-
Rigel PharmaceuticalsCompletedWarm Antibody Autoimmune Hemolytic AnemiaUnited States, Canada
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
Rigel PharmaceuticalsWithdrawn
-
Rigel PharmaceuticalsCompletedRheumatoid ArthritisUnited States, Mexico
-
Genentech, Inc.Biomedical Advanced Research and Development AuthorityCompletedCOVID-19 PneumoniaUnited States, Spain, Brazil, Mexico
-
Emory UniversityNational Cancer Institute (NCI); Verastem, Inc.RecruitingGlioblastoma | Recurrent GlioblastomaUnited States
-
Hoffmann-La RocheActive, not recruitingNeuroblastoma | Solid Tumors | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL)France, United States, Spain, Canada, United Kingdom, Netherlands
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Pfizer; Oncovir, Inc.Completed
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompletedMelanoma (Skin)United States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States